🟢 Moleculin Biotech is trading 5.84% up in pre-market with no clear company-specific catalyst identified

Moleculin Biotech is trading 5.84% up at $0.81 after no clear company-specific catalyst was identified for September 10, 2026.

• The company’s latest listed release was its August 27 investor-conference participation.
• Its September MIRACLE enrollment milestone remains a forward-looking event, not a new announcement.
• Broader markets are mixed, providing no clear explanation for the move.